The principal enzyme of human prostatic acid phosphatase [orthophosphoric monoester phosphohydrolase (acid optimum), EC 3.1.3.2] ,J.vhich had been highly purified by affinity chromatography, isoelectric focusing, and gel filtrations, was shown to be homogeneous at pH 5.0 by sedimentation equilibrium analysis. The amino acid composition was determined and the sedimentation coefficient of the nativemolecule measured.
Assays of Enzyme Activity
The acid phosphatase activity was assayed with 5.5 minol/liter p-nitrophenyl phosphate (Boehringer Mannheim GmbH, Mannheim) as a substrate in 50 mmol/liter citrate buffer at pH 4.8 and +37 #{176}C. After an incubation of 15 mm, the reaction was stopped by adding 2 ml of 20 mmol/liter NaOH and the amount of p-nitrophenol was measured at 400 nm (8) . The method was adapted for a total volume of 220 gil. The enzyme activity was expressed as imol/(min-ml) of the substrate hydrolyzed at 37 #{176}C and the specific activity as imol/(min-mg of protein). This method was used for routine analyses.
In our preliminary studies we found that the reaction was linear with time during the first hour. The following substrates were used in the determination of the relative rate of hydrolysis by acid phosphatase: p-nitrophenyl phosphate, bis(pnitrophenyl) phosphate, phenyl phosphate, glucose-6-phosphate, a-naphthyl phosphate, fl-naphthyl phosphate, naphthol AS-BI-phosphate, adenosine 5'-monophosphate, adenosine 5'-diphosphate, adenosine 5'-triphosphate, sodium pyrophosphate, thiamine pyropho8phate (Sigma Chemical Co., St. Louis, Mo. 63178), fl-glycerophoaphate (Fluka AG, Buchs), and aglycerophosphate (E. Merck A.G., Darmstadt). The incubation medium contained equal amounts of sodium acetate buffer (0.1 mol/liter, pH 5.5) and the enzyme and substrate solutions. The concentration of the substrate solution was 150 mmol/liter for glycerophosphates and 3 mniol/ liter for other substrates, and the incubation time both 15 mm and 30 mm at 37 #{176}C. Acid phosphatase activity was determined by the methods described previously (8) (9) (10) . The enzyme activity was measured as micromoles of p-nitrophenol, naphthol, or asorganic phosphate liberated per milligram of enzyme per minute. Protein concentrations were assayedby measuring the absorbance at 280 nm and by the method of Lowry et al. (11) , with crystalline bovine serum albumin as a standard.
Characterization of the Enzyme
In the eff#{233}ctor studies, pretreatment of the enzyme with the effector substance of analytical grade (E. Merck, if not otherwise mentioned) preceded the addition of the substrate by 15 mm. In the study of thermal inactivation, the enzyme sample was kept at the temperature indicated for 15 mm, then cooled on ice and used for the enzyme assay. The effect of serum on the activity of the purified enzyme was tested as follows. Before the assay,serum was diluted 1 to 1 with tris(hydroxymethyl)aminomethane citrate buffer (0. Purification of the serum factor that inactivated acid phosphatase was attempted by fractionating heated serum on Sephadex G-25 and diethylaminoethyi-cellulose (Pharmacia Fine Chemicals AB, Uppsala). Heated serum, 3 ml, was applied to a 1.6 X 15cm Sephadex G-25 column equilibrated with tris(hydroxymethyl)aminomethane citrate buffer (0.1 molt liter, pH 7.7). The equilibration buffer was used as eluent, at a flow rate of 65 ml/h; 2-ml fractions were collected. The fractions of inactivating factor were pooled and lyophilized. An aliquot, dissolved in 3 ml of the buffer, was applied to a column of diethylaminoethyl-cellulose of dimensions 1.6 cm X 15 cm. The column had been equilibrated with tris(hydroxymethyl)ammnomethane citrate buffer (0.1 mol/liter, pH 7.7) and was eluted with a linear NaCi gradient in the buffer (0-0.5 mol/liter NaCl) at a flow rate of 30 mi/h; 2-ml fractions were collected. The fractions of inactivating factor were again pooled.
Dehydroepiandrosterone sulfate (Steraloids, Inc., Pawling N.Y. 12564) was purified by chromatography on Sephadex LH-20 and Sephadex G-25 (Pharmacia Fine Chemicals AB) before use as an affector (12, 13) . For determination of the pH optimum, citrate buffer (0.1 mol/liter) was used below pH 6.0, and tris(hydroxymethyl)aminomethane citrate buffer was used above pH 6.0. In the determination of Km, p-nitrophenyl phosphate was used as the substrate in 0.1 moi/iiter citrate buffer, pH 5.5. The Km was determined by the method of Lineweaver and Burk (14) . Incubation durations were 5, 10, 15, 20, and 30 mm.
Amino Acid Analysis of the Enzyme
The enzyme (0.4 mg) was dialyzed for 48 h against distilled water, and hydrolyzed in 6 mol/liter HC1 for 24 h in tubes sealed under nitrogen. The sample was evaporated, and the residue analyzed with a JEOL JLC-5AH automatic amino acid analyzer. Cysteine was determined in the form of cysteic acid and methionine as methionine sulfone (15) .
Determination of Molecular Mass and Sedimentation Coefficient by Analytical

Ultracentrifugation
The relative molecular mass of the enzyme was determined by an equilibrium sedimentation method (16) , in a Beckman Model E analytical ultracentrifuge equipped with a photoelectric scanner. The enzyme (0.4 mg/mi) was centrifuged in 10 mmoL'iiter sodium acetate buffer containing 125 mmol/liter of KC1, pH 5.0. The centrifugations were performed at 20#{176}C at 50740rpm in the sedimentation velocity experiments, and at 19 169 rpm in the sedimentation equilibrium experiments.
Results
We have previously described the principal enzyme of human prostatic acid phosphatase (isoelectric point 4.9) to be a single protein when examined by polyacrylamide gel electrophoresis, either as a nondenatured protein or in the presence of sodium dodecyl sulfate (7). The specific activity was 4018 imol/(min.mg) and the purification was 1900-fold, in terms of activity (7). The following preservatives were tested: 200 mg/liter NaN3, 100 mg/liter thimerosal, and 100 mg/liter thymol. They did not affect the enzyme activity. We used 100 mg/liter thymol as preservative, if necessary. The analytical recovery of the enzyme after one year in sodium acetate buffer (0.1 mol/liter, pH 5.0) at -20 #{176}C was about 9096, and at -4 #{176}C about 80% after four months of storage. The enzyme was stable during iyophilization. The metal ions tested (Ba2, Ca2, Cd2t Co2, Cu2+, Mg2+, Mn2+, Ni2+, Sn2+, Zn2+) in concentrations of 0.005 to 55 mmol/iiter were without substantial effects. Sulfates, acetates, and chlorides of Na and K had no effect in the concentrations mentioned above. Heparin (Serva, Heidel- (Table 3) .
Serum inhibited acid phosphatase, even in dilutions as great as 32-to 64-fold. Heated human serum inactivated the enzyme noncompetitively and the reaction was calculated to follow first-order kinetics. At pH 7.7, heated undialyzed serum accelerated the inactivation of the enzyme (Figure 1 ). Dialyzed serum stabilized the enzyme at pH values below 7.7. Dialysis of serum against isotonic saline abolished its ability to inactivate acid phosphatase, and after concentration of serum to half of its volume by use of a Diaflo UM-2 membrane, an a!- Fig. 1 . Effect of heated serum on activity at 37 #{176}C #{149}-#{149}, activity of the enzyme incubated with citrate buffer, pH 7.7. 0-0, activity of the enzyme incubated with heated serum, pH 7.7 most equal concentration of inhibiting activity was found in both the concentrate and ultrafiltrate. When serum was diluted with an equal volume of saline, heated for 10 mm at 100 #{176}C, and centrifuged, all the inhibiting activity was found in the supernate.
In gel filtration, most of the proteins of the heated serum were eluted in the void volume of the column, while the inhibiting activity was eluted at the total volume of the column (Figure 2 ). In addition, a third ultraviolet-absorbing peak was eluded at 1.6-fold the total volume of the column. The materials in this peak were strongly retarded by the gel matrix. The pooled acid-phosphatase-inactivating factor was adsorbed onto diethylaminoethyl-cellulose and was eluted with NaCl (60 mmol/liter) of conductivity 4.85 mS. The inactivating factor of serum has a very low relative molecular mass, because it diffuses through a dialysis membrane and is eluted in a volume corresponding to the total volume of the Sephadex The amino acid analysis of the enzyme (Table 4) was calculated, from mean results of three separate experiments, as residues per 1000 amino acid residues.
In 10 mmol/liter sodium acetate buffer containing 125 mmol of KC1 per liter, pH 5.0, acid phosphatase showed a single and very symmetrical boundary on analytical ultracentrifugation. Determination of the sedimentation coefficient gave the value S2o,2oc = 6.08 S. The relative molecular mass as measured by sedimentation equilibrium was 89 000 (Figure 3 ).
Discussion
We recently described the purification of the principal enzyme of human prostatic acid phosphatase (p14.9) (7). In the present report, the purified enzyme is characterized.
As could be expected, several properties of the preparation I report about a 15% higher concentration of methionine. The relative molecular mass of the enzyme obtained by analytical ultracentrifugation indicated that the enzyme was still undissociated (4). The relative molecular mass is lower than described by Derechin et al. (4) . The enzyme preparation used by Derechin et al. had isoelectric points of 4.8,4.9, and 5.15 in isoelectric focusing. The enzyme preparation described here had only one isoelectric point, at 4.9, in isoelectric focusing. The mobility of the enzyme during gel filtration on a Sephadex G-200 column corresponded to the mobility of a globular protein of 109 000 daltons, as previously reported (7) . The sugar content of the enzyme may lead to retardation of the molecule on gel filtration, which may explain the difference in relative molecular mass as assessed by gel filtration and by ultracentrifugation.
Several factors were also investigated in relation to their possible effects on the prostatic enzyme activity. Heparin, which is known to inhibit leukocyte acid phosphatase (17) , was also found to inhibit human prostatic acid phosphatase. This enzyme is also sensitive to heat and alkaline pH. The anions are reported to be effective accelerators, not only in the thermal denaturation process, but also for inactivation at alkaline pH (18) .
Serum at alkaline pH inactivated the enzyme, as noticed by Woodard (19) . We found this to be a first-order reaction. According to Woodard, inactivation of prostatic acid phosphatase in the presence of serum is caused by the alkaline pH of serum. From my results I conclude that pH is not the only factor, because a distinct peak of inactivating factor was obtained in the gradient elution of the serum from diethylaminoethyl-cellulose, where changes of pH were minimal and continuous in all fractions. Nor is it merely the high salt concentration, since NaCl, which had an equal conductivity as the peak obtained after Sephadex G-25 gel filtration, did not inhibit as much as the gel-filtered preparation. Li et al. (20) studied the inactivation of acid phosphatase isoenzymes by heparmnized plasma and noticed that isoenzymes 2 (the principal isoenzyme of prostatic acid phosphatases) and 4 were most rapidly inactivated and that isoenzyme 5 activity increased after treatment of plasma at 37#{176}C, while the activity of isoenzyme 1 was unchanged. The possible role of blood plasma in the above results is difficult to evaluate, because I have shown that heparin alone inactivates prostatic acid phosphatase. Dehydrepiandrosterone sulfate in high concentrations inhibits the enzyme, but only at concentrations much higher than those reported in normal male serum (21) . This steroid conjugate also inhibits acid phoephatase synthesis in prostatic tissue culture (22) .
My results suggest that the acid phosphatase inactivating factor of serum is a heat-stable, dialyzable compound of low relative molecular mass and its retention by diethylaminoethyl-cellulose suggests an anionic character. The inhibition is not reversible. Perhaps the anions accelerate the dissociation of the enzyme (Figure 1 ). Dialyzed serum as well as bovine serum albumin, on the contrary, protected the enzyme. In view of the present studies, the possible reason for the contradictory results obtained when attempting to correlate serum phosphatase activity with prostatic carcinoma may be at least partly in the preparation of serum samples, where small differences in clotting and storage conditions and times may cause great variations in the survival of the enzyme. 
